Joseph Edelman, 10% Owner at Aldeyra Therapeutics, Inc. (ALDX), bought 97,000 shares at $7.24 ($702K) on 2022-08-08, disclosed to the SEC on 2022-08-10.
Open-market purchase of $702k ALDX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |